New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 16, 2013
11:09 EDTAGN, NSRGYAllergan an ideal candidate to buy Galderma, says Cowen
Cowen said earlier today that its talks with industry contacts indicate Nestle (NSRGY) and Loreal may be contemplating a sale of dermatology company Galderma. Cowen believes Allergan (AGN) is an ideal candidate to buy the company given its balance sheet flexibility and keeps an Outperform rating on the stock with a $145 price target. Shares of Allergan are up 3% in morning trading to $99.54.
News For AGN;NSRGY From The Last 14 Days
Check below for free stories on AGN;NSRGY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
06:28 EDTNSRGYNespresso agrees to change commercial behavior in France, WSJ reports
Subscribe for More Information
April 16, 2014
10:00 EDTAGNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: A10 Networks (ATEN) initiated with a Buy at BofA/Merrill... Actavis (ACT) initiated with a Buy at Sterne Agee... Allergan (AGN) initiated with a Buy at Sterne Agee... Autohome (ATHM) initiated with a Neutral at Credit Suisse... BitAuto (BITA) initiated with an Outperform at Credit Suisse... Centene (CNC) initiated with a Neutral at UBS... Endo International (ENDP) initiated with a Buy at Sterne Agee... FS Investment (FSIC) initiated with an Overweight at Evercore... Hertz (HTZ) initiated with a Buy at Gabelli... Hilton (HLT) initiated with a Hold at Jefferies... Hospira (HSP) initiated with a Neutral at Sterne Agee... ImmunoGen (IMGN) initiated with a Buy at Canaccord... Impax (IPXL) initiated with a Neutral at Sterne Agee... Imperva (IMPV) assumed with a Neutral at Wedbush... Ingredion (INGR) initiated with an Outperform at Credit Suisse... Laredo Petroleum (LPI) initiated with an Outperform at RW Baird... Lpath (LPTN) initiated with a Buy at Canaccord... MediWound (MDWD) initiated with an Outperform at Oppenheimer... Medivation (MDVN) initiated with a Hold at Canaccord... NPS Pharmaceuticals (NPSP) assumed with a Buy at Canaccord... Nimble Storage (NMBL) initiated with a Market Perform at Raymond James... Regeneron (REGN) initiated with a Buy at Canaccord... Salix (SLXP) initiated with a Buy at Sterne Agee... Sibanye Gold (SBGL) initiated with an Outperform at Imperial Capital... Teva (TEVA) initiated with a Neutral at Sterne Agee... Wipro (WIT) assumed with a Hold at Jefferies.
07:04 EDTAGNAllergan initiated with a Buy at Sterne Agee
Target $142.
April 15, 2014
05:10 EDTNSRGYNestle confirms FY14 organic growth guidance around 5%
Subscribe for More Information
05:08 EDTNSRGYNestle reports Q1 revenue CHF 20.8B vs. CHF 21.94B last year
Subscribe for More Information
April 11, 2014
18:44 EDTAGNJ&J halting development of Botox competitor, WSJ says
Subscribe for More Information
13:35 EDTNSRGYNestle chairman requires medical treatment
The Nestlé board of directors was informed yesterday that Peter Brabeck-Letmathe, chairman of the board, has been diagnosed with an illness which is curable but requires periodic medical treatment over the next six months. The company said that this does not affect Brabeck-Letmathe’s ability to carry out his role as chairman of the Nestlé board of directors and he will continue to fully exercise his duties during the treatment period. Reference Link
April 10, 2014
12:04 EDTNSRGYNestle says slowdown could spark sales of underperforming units, WSJ says
Nestle plans to continue to to sell underperforming divisions as part of its on-going product-and-brand review, according to The Wall Street Journal, citing comments from CEO Paul Bulcke. CEO Bulcke said, "We are looking at our product and brand portfolio and analyzing it through a sharper, stricter lens. We are making choices about where we want to invest, where we want to improve and areas we want to divest." Reference Link
April 9, 2014
13:35 EDTNSRGYHershey melts after Goldman downgrade
Shares of chocolate maker Hershey (HSY) are falling after Goldman Sachs lowered its rating on the stock to a Sell. WHAT'S NEW: After the market closed last night, Goldman Sachs downgraded Hershey to Sell from Neutral, saying the stock is "priced for perfection" and that the company's cycle of strong earnings growth will end. Goldman lowered its price target for the stock to $90 from $105. Goldman Sachs analysts Jason English, Sean King and Manpreet Sethl were cautious on Hershey, saying that they expect the company's domestic momentum to fade. Goldman lowered its earnings per share estimates for Hershey's fiscal years 2014 through 2016 by 3%-6% to reflect lower sales and margin projections. While they said that they still perceive Hershey as a "best-in-breed company" whose international momentum will continue, the analysts believe expectations for the company are on the verge of turning more negative. OTHERS TO WATCH: Other companies in the chocolate industry include Nestle (NSRGY) and Mondelez (MDLZ), which owns Cadbury. PRICE ACTION: During afternoon trading, shares of Hershey fell $2.57 or $2.53%, to $99.15.
07:29 EDTNSRGYKellogg speculated as Berkshire target amid volatile trading, Bloomberg says
Kellogg (K) shares have surged over last week amid speculation the company may be a takeover target for Warren Buffett’s Berkshire Hathaway (BRK.A), said Bloomberg's "Real M&A" column, which noted that Kellogg fits the financial criteria for the types of acquisitions Buffet has made in the past. Kellogg could also appeal to another food company, like PepsiCo (PEP) or Nestle (NSRGY), the report added. Reference Link
April 7, 2014
07:23 EDTNSRGYNestle's chairman Brabeck to step down in FY17, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use